neuroscience
| 5 min read
Industry leaders predict the most exciting advances in drug discovery and development in the coming year.
| 3 min read
The FDA approved two new medications for Niemann-Pick disease type C that improve symptoms, showing the power of community advocacy.
| 9 min read
Ketamine effectively treats depression, but recent studies illustrate the ongoing difficulties in understanding its antidepressant effects at a molecular level.
| 5 min read
Breast cancer cells can pass through the bone marrow to reach the tissues surrounding the brain and spinal cord in mice — a new way for cancer to spread.
| 9 min read
Rodent studies and clinical trials increasingly demonstrate the soothing effects of green light, and now, researchers are revealing the underlying neural mechanisms.
| 3 min read
Epilepsy onset and seizure severity are linked to variants in the SCN2A gene, potentially leading to improved diagnostics and treatments.
| 4 min read
Stimulating dopamine neurons in adolescent mice rescued cognitive deficits associated with future development of neuropsychiatric disorders.
| 10+ min read
Once symptoms show up, it’s too late to cure many autoimmune diseases. Researchers are investigating ways to prevent the conditions from starting at all.
| 2 min read
Dopamine stimulators may lessen the systemic side effects — often weight gain and diabetes — of dopamine-blocking antipsychotics.
| 4 min read
Scientists recovered movement in mouse models of spinal cord injury.
Page 1 of 12 - 115 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe